Pfizer is one of the world's largest pharmaceutical companies, discovering, developing, and manufacturing biopharmaceutical products across oncology, vaccines, internal medicine, inflammation and immunology, and rare disease. Major products include the Prevnar pneumococcal vaccine franchise, cancer medicines including Ibrance, Xtandi, Padcev, and Adcetris from its $43 billion Seagen acquisition, the Vyndaqel cardiomyopathy franchise, Eliquis anticoagulant partnered with Bristol Myers Squibb, and the COVID-19 vaccine Comirnaty (with BioNTech) and treatment Paxlovid. Following the pandemic-era windfall and subsequent decline, Pfizer has focused on cost restructuring, oncology depth, and pipeline renewal, including obesity candidates. Founded in 1849 by cousins Charles Pfizer and Charles Erhart, the company is headquartered in New York City and sells in most countries worldwide.

Insider Buy

Beneish M-Score

Tax Rate

Dividend Payout Ratio

PB Ratio

PE Ratio

Revenue per Share

Price

PS Ratio

Dividend Yield %

Altman Z-Score

Pfizer Inc